Despite the insider sales (and the high P/FCF and, gasp, P/S) in my full holding in MANH, I run the calcs. and can make no case at all for top-slicing.

Rare is the company with such figures but clearly, a certain wariness is warranted even if RS continues; flattening in the last month or so, no doubt due to the sales.